Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ACA Cancellation Notices – From Pharma

This article was originally published in RPM Report

Executive Summary

The Together Rx drug discount program is shutting down in February, with members told that they may have better options in the new health care exchange. That message unfortunately resonates differently than intended in the current climate of concern about insurers cancelling policies ahead of the exchange launch. But, overall, Big Pharma probably has more reasons than ever to maintain patient assistance programs, at least until the ACA launch shakes out.

You may also be interested in...



Together Rx Patient Assistance Program Will Close When ACA Coverage Expansion Begins

The move to shutter the program is noteworthy because it suggests the beginning of a trend among patient assistance programs for drugs as the uninsured gain coverage through state marketplaces or Medicaid.

PhRMA Launching National Patient Assistance Clearinghouse April 5

The Pharmaceutical Research & Manufacturers of America's "Partnership for Patient Assistance" clearinghouse for prescription drug support programs will roll out nationwide April 5

Pfizer Takes Part In “Together Rx Access”; Merck Plans Separate Card

Pfizer is joining the "Together Rx" group as it rolls out a discount program for the non-Medicare population

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel